Added to YB: 2024-08-02
Pitch date: 2024-06-30
PCVX [bullish]
Vaxcyte, Inc.
-41%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Vaxcyte, Inc., a clinical-stage vaccine innovation company, develops conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases.
Market Cap
$6.4B
Pitch Price
$75.43
Price Target
N/A
Dividend
N/A
EV/EBITDA
-6.04
P/E
-10.06
EV/Sales
N/A
Sector
Biotechnology
Category
growth
Show full summary:
ClearBridge Small Cap Growth Strategy New Position: Vaxcyte, Inc.
PCVX: Biopharma co developing novel vaccines for bacterial diseases. Platform tech aims for broadest spectrum coverage in $8B+ annual market. Potential for dominant position in adult/infant vaccines. Differentiated approach could capture significant market share.
Read full article (1 min)